Back to mobile site

Chardan Downgrades Silence Therapeutics (SLN) to Neutral

October 19, 2026 9:16 AM EDT Send to a Friend
Chardan analyst Keay Nakae downgraded Silence Therapeutics (NASDAQ: SLN) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login